BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in ANIK — Anika Therapeutics, Inc.
CIK 1107261
HOUSTON, TX
Position in ANIK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$253,750
+$85,575 QoQ
Shares Held
17,500
0.0% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $35,934,652 across 16 Drug Manufacturers - Specialty & Generic names. ANIK ranks #13 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
411,373 | $9,297,029 | |
| 2 | PRGO |
PERRIGO Co plc
|
815,347 | $8,756,826 | |
| 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
330,457 | $6,473,652 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
48,000 | $2,481,120 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,620 | $1,553,607 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
440,493 | $1,546,130 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
106,449 | $1,323,161 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
35,000 | $1,066,800 |
All Filings in ANIK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $253,750 | 17,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $168,175 | 17,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $164,500 | 17,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $185,150 | 17,500 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||